Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:18 PM
Ignite Modification Date:
2026-03-26 @ 3:18 PM
NCT ID:
NCT07308067
Eligibility Criteria:
Inclusion Criteria:
* Adult Patients (≥ 18 years old) diagnosed with Crohns disease according to ECCO guidelines
* Initiating risankizumab therapy in routine practice
* Undergoing IUS procedures before and after risankizumab therapy
Exclusion Criteria:
* Ulcerative colitis and unclassified colitis
* Follow-up shorter than 3 months (except for those discontinuing risankizumab due to side effect or failure)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07308067
Study Brief:
Protocol Section:
NCT07308067